Kidney cancer cell proliferation relies on the suppression of tumour cell-intrinsic type I IFN activity, and our findings that disruption of CBF-β function can activate a cell-intrinsic ISG response in ccRCC cells provide avenues to overcome this repression. The gene discussed is CBFB; the disease is neoplasm.